Unrelated cord blood transplantation can restore hematologic and immunologic functions in patients with Chediak-Higashi syndrome

Pediatric Transplantation

Volumn 16, Issue 4, 2012, Pages

  Rihani, Rawad ^a   Barbar, Maha ^a   Faqih, Nesreen ^a   Halalsheh, Hadeel ^a   Hussein, Ayad Ahmad ^a   Al Zaben, Abdul Hadi ^a   Rahman, Fawzi Abdel ^a   Sarhan, Mahmoud ^a  

^a KING HUSSEIN CANCER CENTER   (Jordan)

Author keywords

accelerated phase; Chediak Higashi Syndrome; cord blood transplantation; hematopoietic stem cell transplantation

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; ETOPOSIDE; FOLINIC ACID; GRANULOCYTE COLONY STIMULATING FACTOR RECEPTOR; HLA ANTIGEN; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT VERSUS HOST DISEASE; CASE REPORT; CHEDIAK HIGASHI SYNDROME; CHILD; CHILD DEVELOPMENT; CHILD GROWTH; CLINICAL FEATURE; CORD BLOOD STEM CELL TRANSPLANTATION; CORTICOSTEROID THERAPY; CYTOMEGALOVIRUS INFECTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; GRAFT VERSUS HOST REACTION; HISTOCOMPATIBILITY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFANT; MALE; MEDICAL RECORD REVIEW; MORBIDITY; OUTCOME ASSESSMENT; PARAMYXOVIRUS INFECTION; PRESCHOOL CHILD; RECURRENT DISEASE; RESPIRATORY FAILURE; REVIEW; SURVIVAL RATE;

CHEDIAK-HIGASHI SYNDROME; CORD BLOOD STEM CELL TRANSPLANTATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; MALE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84861191334     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2010.01461.x     Document Type: Review

References (20)

1. Abo T, Roder JC, Abo W, Cooper MD, Balch CM,. Natural killer (HNK-1+) cells in Chediak-Higashi patients are present in normal numbers but are abnormal in function and morphology. J Clin Invest 1982: 70: 193-197. (Pubitemid 12090839)
2. Bellinati-Pires R, Salgado MM, Joazeiro PP, Carneiro-Sampaio MM,. Delayed phagocytosis and bacterial killing in Chediak-Higashi syndrome neutrophils detected by a fluorochrome assay. Ultrastructural aspects. Mem Inst Oswaldo Cruz 1992: 87: 575-581.
3. Barak Y, Nir E,. Chediak-Higashi syndrome. Am J Pediatr Hematol Oncol 1987: 9: 42-55. (Pubitemid 17038773)
4. Rubin CM, Burke BA, McKenna RW, et al., The accelerated phase of Chediak-Higashi syndrome. An expression of the virus-associated hemophagocytic syndrome? Cancer 1985: 56: 524-530. (Pubitemid 15035580)
5. Introne W, Boissy RE, Gahl WA,. Clinical, molecular, and cell biological aspects of Chediak-Higashi syndrome. Mol Genet Metab 1999: 68: 283-303. (Pubitemid 29501101)
6. Eapen M, DeLaat CA, Baker KS, et al., Hematopoietic cell transplantation for Chediak-Higashi syndrome. Bone Marrow Transplant 2007: 39: 411-415. (Pubitemid 46487306)
7. Liang JS, Lu MY, Tsai MJ, Lin DT, Lin KH,. Bone marrow transplantation from an HLA-matched unrelated donor for treatment of Chediak-Higashi syndrome. J Formos Med Assoc. 2000: 99: 499-502
8. Bejaoui M, Veber F, Girault D, et al., The accelerated phase of Chediak-Higashi syndrome. Arch Fr Pediatr 1989: 46: 733-736.
9. Haddad E, Le Deist F, Blanche S, et al., Treatment of Chediak-Higashi syndrome by allogenic bone marrow transplantation: Report of 10 cases. Blood 1995: 85: 3328-3333.
10. Virelizier JL, Lagrue A, Durandy A, et al., Reversal of natural killer defect in a patient with Chediak-Higashi syndrome after bone-marrow transplantation. N Engl J Med 1982: 306: 1055-1056.
11. Ouachee-Chardin M, Elie C, De Saint Basile G, et al., Hematopoietic stem cell transplantation in hemophagocytic lymphohistiocytosis: A single-center report of 48 patients. Pediatrics 2006: 117: e743-750. (Pubitemid 46071479)
12. Baker KS, Filipovich AH, Gross TG, et al., Unrelated donor hematopoietic cell transplantation for hemophagocytic lymphohistiocytosis. Bone Marrow Transplant 2008: 42: 175-180.
13. Rocha V, Gluckman E,. Clinical use of umbilical cord blood hematopoietic stem cells. Biol Blood Marrow Transplant 2006: 12: 34-41. (Pubitemid 43034117)
14. Henter JI, Horne A, Arico M, et al., HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2007: 48: 124-131. (Pubitemid 44958267)
15. Rocha V, Cornish J, Sievers EL, et al., Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood 2001: 97: 2962-2971.
16. Tardieu M, Lacroix C, Neven B, et al., Progressive neurologic dysfunctions 20 years after allogeneic bone marrow transplantation for Chediak-Higashi syndrome. Blood 2005: 106: 40-42. (Pubitemid 40967172)
17. Amrolia P, Gaspar HB, Hassan A, et al., Nonmyeloablative stem cell transplantation for congenital immunodeficiencies. Blood 2000: 96: 1239-1246. (Pubitemid 30658449)
18. Cooper N, Rao K, Gilmour K, et al., Stem cell transplantation with reduced-intensity conditioning for hemophagocytic lymphohistiocytosis. Blood 2006: 107: 1233-1236. (Pubitemid 43156331)
19. Ayas M, Al-Ghonaium A,. In patients with Chediak-Higashi syndrome undergoing allogeneic SCT, does adding etoposide to the conditioning regimen improve the outcome? Bone Marrow Transplant 2007: 40: 603. (Pubitemid 47382134)
20. Kaplan J, De Domenico I, Ward DM,. Chediak-Higashi syndrome. Curr Opin Hematol 2008: 15: 22-29. (Pubitemid 350191025)